KeraNetics, Inc

KeraNetics is the global leader in keratin science, purified, human-derived keratin manufacture, research and development for healthier wound healing KeraNetics provides physicians with new options to help patients by exploiting the properties of purified, human-derived keratin. KeraStat Cream: Better management of radiation dermatitis (RD). KeraStat Cream harnesses the power of keratin proteins to support the management of dry, light, and moderately exuding partial thickness skin wounds such as radiation dermatitis resulting from a fractionated radiotherapy regimen. FDA cleared and available in 1 oz. and 5 mL tubes. Rx only

Human derived keratin protein,wound dressings,cutaneous radiation injury,research,breast cancer,head neck cancer,radiation dermatitis,radiation oncology,oncologist,radiation burn,dermatology,doctors patients,skin toxicities,and diabetic ulcers

Keranetics, inc operates in the Biotechnology research industry.

Keranetics, inc's revenue is 1m - 10m

Keranetics, inc has 11 - 50 employees.